Clinical Trial Update: Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above [Phase 2]

View source ↗

Summary

Phase II clinical trial update for a lyophilized herpes zoster mRNA vaccine in adults aged 40 and above; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Varicella

Drugs mentioned

• Lyophilized Herpes Zoster mRNA Vaccine

Snippet

Sponsor: Suzhou Abogen Biosciences Co., Ltd. | Conditions: Varicella-zoster Virus | Phase 2 | Status: ACTIVE_NOT_RECRUITING